Skip to content

DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects

Solomon H. Snyder, Louis A. Faillace, Herbert Weingartner

American Journal of Psychiatry September 1, 1968 DOI: 10.1176/ajp.125.3.357 via OpenAlex

Summary

AI-generated from the abstract

In a double-blind study, normal subjects given small doses of DOM (a hallucinogen related to mescaline and amphetamine, also known as STP) and its ethyl homologue DOET experienced increased self-awareness and mild euphoria without hallucinogenic or psychotomimetic effects. Both drugs freed up word associations without impairing memory or concentration; DOM even enhanced performance on serial learning tasks. DOM did not affect visual discrimination but altered perception of tachistoscopically presented TAT cards.

Study at a glance

Characteristics Double-blind study Peer reviewed
Population Normal subjects
Interventions DOM DOET
Dose small doses
Topics LSD MDMA Mescaline Psilocybin
Keywords Hallucinogen Euphoriant Psychology Psychotomimetic
Citations 77
Key finding Small doses of DOM and DOET increased self-awareness and produced mild euphoria without hallucinogenic effects, and DOM enhanced serial learning performance.

Abstract

DOM, a hallucinogen related to mescaline and amphetamine and designated "STP" by hippies, along with DOET, the ethyl homologue of DOM, were given in small doses to normal subjects in a double-blind study. Both drugs increased self-awareness and produced mild euphoria but no hallucinogenic or psychotomimetic effects. The two drugs "freed up" subjects' word associations without impairing memory or concentration; in fact, DOM enhanced performance on serial learning tasks. Although DOM did not affect visual discrimination, it altered the perception of tachistoscopically presented TAT cards.

Explore topics

Comments

No comments yet.

Log in to comment